Boston Scientific
- Left Atrial Appendage Closure (LAAC)
- Mapping and Ablation
- Venous Therapies
- Cardiac Rhythm Management
- Structural Heart
- Interventional Oncology
- Drug-Eluting Technologies
- Coronary
Playback speed
10 seconds
Select Locoregional therapies as a COVID-19 Risk Mitigation treatment strategy for HCC
162 views
September 2, 2020
Watch to hear Drs Riad Salem, Edward Kim, Pavan Khanna and Juan Gimenez speak about ...
read more ↘ recommendations and suggestions on how to manage the HCC in this COVID era.
↖ read less
read more ↘ recommendations and suggestions on how to manage the HCC in this COVID era.
↖ read less
Login to view comments.
Click here to Login
Interventional Oncology
Wed, Nov 3, 2021
Faculty: Boston Scientific , Riad Salem , Juan Gimenez , Robert Lewandowski , Shamar Young
Faculty: Boston Scientific , Riad Salem , Juan Gimenez , Robert Lewandowski , Shamar Young